Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Predictive Oncology Inc. Director's Dealing 2013

Nov 27, 2013

35106_dirs_2013-11-27_6b7c196f-3058-4ef5-ad41-7c64abb6b0bd.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Skyline Medical Inc. (SKLN)
CIK: 0001446159
Period of Report: 2013-11-26

Reporting Person: Herschkowitz Samuel (10% Owner)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2013-11-26 Common Stock, par value $0.01 per share P 10000 $0.29 Acquired 46627866 Direct